Search

Your search keyword '"Monard L"' showing total 5 results
Start Over Author "Monard L" Publisher elsevier b.v.
5 results on '"Monard L"'

1. 925P External validation of the CD8 radiomics signature as a prognostic marker in recurrent or metastatic head and neck cancer treated with nivolumab.

Author

Adrien, L., Even, C., Hano, J.B., Deny, N., Mitrea, D., Tao, Y., Lefebvre, G., Daste, A., Saada, E.B., Fayette, J., Blanchard, P., Cifliku, V., Talebi, F., Monard, L., Texier, M., Robert, C., Classe, M., Auperin, A., Deutsch, E., and Sun, R.

Subjects
*HEAD & neck cancer, *PROGNOSIS, *RADIOMICS, *CD8 antigen, *NIVOLUMAB
Published
2024
Full Text
View/download PDF

2. 940P Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial.

Author

Saleh, K., Texier, M., Iacob, M., Daste, A., Fayette, J., Lefebvre, G., Saada, E.B., Zanetta, S., Vinches, M., Toullec, C., Salas, S., Kaminsky-Forrett, M-C., Johnson, A.C., Sire, C., N. Khalife-saleh, Ferrand, F.R., Monard, L., Auperin, A., and Even, C.

Subjects
*SQUAMOUS cell carcinoma, *NIVOLUMAB, *NECK, *CANCER chemotherapy, *HEAD
Published
2023
Full Text
View/download PDF

3. 675P Patterns of radiological responses to anti-PD1 in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study.

Author

Even, C., Bernard-Tessier, A., Texier, M., Ben Said, O., Iacob, M., Daste, A., Fayette, J., Zanetta, S., Lefebvre, G., Vinches, M., Johnson, A.C., Bozec Le Moal, L., Saada, E.B., Jallut, I., Garic, F., Monard, L., Bourhis, J., Guigay, J., Auperin, A., and Ammari, S.

Subjects
*SQUAMOUS cell carcinoma, *NECK, *METASTASIS, *HEAD
Published
2022
Full Text
View/download PDF

4. LBA68 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER.

Author

Duffaud, F., Blay, J-Y., Mir, O., Chevreau, C.M., Rouquette, P. Boudou, Kalbacher, E., Penel, N., Perrin, C., Laurence, V., Bompas, E., Saada-Bouzid, E., Delcambre, C., Bertucci, F., Cancel, M., Schiffler, C., Monard, L., Bouvier, C., Vidal, V., Gaspar, N., and Chabaud, S.

Subjects
*EWING'S sarcoma, *SARCOMA, *REGORAFENIB, *PLACEBOS, *METASTASIS
Published
2020
Full Text
View/download PDF

5. P-080 - Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI).

Author

Samalin, E., Turpin, A., Khemissa, F., Zaanan, A., Benabdelghani, M., Senellart, H., Gilabert, M., Evesque, L., Dahan, L., Sefrioui, D., Bouché, O., De la Fouchardière, C., Hennequin, A., Monard, L., Gourgou, S., and Lopez, A.

Subjects
*IRINOTECAN, *ADENOCARCINOMA, *REGORAFENIB, *METASTASIS, *THERAPEUTICS
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results